Primary hyperoxaluria type 1: strategy for organ transplantation
- PMID: 20733487
- DOI: 10.1097/MOT.0b013e32833e35f5
Primary hyperoxaluria type 1: strategy for organ transplantation
Abstract
Purpose of review: Primary hyperoxaluria type 1, the most common form of primary hyperoxaluria, is an autosomal recessive disorder caused by a deficiency of the liver-specific enzyme alanine:glyoxylate aminotransferase. This results in increased synthesis and subsequent urinary excretion of the metabolic end-product oxalate and the deposition of insoluble calcium oxalate in the kidney and urinary tract. As glomerular filtration rate decreases due to progressive renal involvement, oxalate accumulates and results in systemic oxalosis.
Recent findings: Diagnosis is still often delayed. It is mainly established on the basis of clinical and sonographic findings, urinary oxalate ± glycolate assessment, and DNA analysis.
Summary: Following specific conservative measures, the ultimate management is based on organ transplantation. Correction of the enzyme defect by liver transplantation should be planned before systemic oxalosis develops to optimize outcomes and may be either simultaneous (immunological benefit) or sequential (biochemical benefit) liver-kidney transplantation depending on disease staging, facilities, and access to deceased or living donors. Allograft and patient survival currently approaches that of transplant patients with kidney transplantation alone and with other diseases requiring combined liver-kidney transplantation. In addition, this strategy has also provided significant improvement in both quality of life and statural growth.
Similar articles
-
Primary hyperoxaluria type 1: still challenging!Pediatr Nephrol. 2006 Aug;21(8):1075-81. doi: 10.1007/s00467-006-0124-4. Epub 2006 Jun 30. Pediatr Nephrol. 2006. PMID: 16810517 Review.
-
[Primary hyperoxaluria].Nephrol Ther. 2011 Jul;7(4):249-59. doi: 10.1016/j.nephro.2011.03.004. Epub 2011 Jun 2. Nephrol Ther. 2011. PMID: 21636340 French.
-
Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1.Clin Transplant. 1997 Oct;11(5 Pt 1):361-5. Clin Transplant. 1997. PMID: 9361924
-
[Primary hyperoxaluria].Nephrologie. 1995;16(6):399-406. Nephrologie. 1995. PMID: 8524446 Review. French.
-
Renal transplantation in a child with primary oxalosis.Child Nephrol Urol. 1990;10(2):103-6. Child Nephrol Urol. 1990. PMID: 2253246
Cited by
-
Diagnosis and management of primary hyperoxalurias: best practices.Pediatr Nephrol. 2024 May 16. doi: 10.1007/s00467-024-06328-2. Online ahead of print. Pediatr Nephrol. 2024. PMID: 38753085 Review.
-
Restored glyoxylate metabolism after AGXT gene correction and direct reprogramming of primary hyperoxaluria type 1 fibroblasts.iScience. 2024 Mar 21;27(4):109530. doi: 10.1016/j.isci.2024.109530. eCollection 2024 Apr 19. iScience. 2024. PMID: 38577102 Free PMC article.
-
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1.EMBO Mol Med. 2024 Jan;16(1):112-131. doi: 10.1038/s44321-023-00008-8. Epub 2024 Jan 5. EMBO Mol Med. 2024. PMID: 38182795 Free PMC article.
-
Complications in Post-Liver Transplant Patients.J Clin Med. 2023 Sep 24;12(19):6173. doi: 10.3390/jcm12196173. J Clin Med. 2023. PMID: 37834818 Free PMC article. Review.
-
Treatment of primary hyperoxaluria type 1.Clin Kidney J. 2022 May 17;15(Suppl 1):i9-i13. doi: 10.1093/ckj/sfab232. eCollection 2022 May. Clin Kidney J. 2022. PMID: 35592620 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials